EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen, CHMP, 29/04/2021

EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen, CHMP, 29/04/2021

SEMrush
EMA has started evaluating an application to extend the use of Olumiant (baricitinib) to include treatment of COVID-19 in hospitalised patients from 10…
[automaticbacklinks]